Latest filing published 21 Mar 2014 for Sucampo Pharmaceuticals, Inc., €3,800.
Insider track record
No signal scores available.
Gayle R. Dolecek: trading record in brief
This profile gathers the share dealings of Gayle R. Dolecek in Sucampo Pharmaceuticals, Inc. We count 7 filings; the first trade dates from 16 December 2013 and the latest from 18 March 2014.
No open-market purchase appears, only 3 sales worth €121k. The rest of the record consists of 1 share grant and 3 option exercises. Since January 2014: no purchases and 3 sales on the market.
The record was last updated on 21 March 2014 with an option exercise (€3,800) in Sucampo Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gayle R. Dolecek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,200 shares@ US$4.41Class A Common StockSEC:0001171843-14-001374:0
- 1,200 shares@ US$8.03Class A Common StockSEC:0001171843-14-001374:1
- 9,067 shares@ US$4.41Class A Common StockSEC:0001171843-14-000871:0
- 9,067 shares@ US$8.04Class A Common StockSEC:0001171843-14-000871:1
- 9,066 shares@ US$4.41Common StockSEC:0001171843-14-000307:0
- 9,066 shares@ US$9.21Common StockSEC:0001171843-14-000307:1
- 54,400 shares@ US$8.00Class A Common StockSEC:0001171843-13-005083:0
7 of 7 declarations
